Why the study?
Are serum levels of microRNA-21, microRNA-125a, microRNA-125b, and microRNA-214 associated with the presence and clinical features of coronary artery disease?
Are serum levels of microRNA-21, microRNA-125a, microRNA-125b, and microRNA-214 associated with the presence and clinical features of coronary artery disease?
Elevated serum expression of microRNA-21, -125a, -125b, and -214 is significantly associated with the presence of coronary artery disease and a history of myocardial infarction.
Background. Coronary artery disease (CAD) is determined by interaction of environmental factors with epigenetic and genetic factors. MicroRNA-21, microRNA-125a, microRNA-125b and microRNA-214 are small non-coding RNAs and the most important regulators of gene expression. MicroRNA-21, -125a, -125b and -214 are insufficiently studied in CAD patients. Objective. To explore serum expression of microRNA-21, microRNA-125a, microRNA-125b, microRNA-214 in CAD patients with different features of clinical course. Material and methods. The study included 129 CAD patients (men 56.6% and women 43.4%) aged 63.17±8.57 years. The comparison group consisted of 45 people without CAD (men 55.6% and women 44.4%) aged 62.09±8.79 years (p>0.05). Serum microRNA expression was analyzed using real-time polymerase chain reaction. Relative microRNA expression was estimated in accordance with standard 2-ΔCt procedure. Results. Serum expression of microRNA-21, microRNA-125a, microRNA-125b and microRNA-214 is higher in CAD patients (p<0.001). MicroRNA-21 expression >16.43 units increases the risk of CAD by 3.49 times (HR 3.49, 95% CI 1.70—7.17, p<0.001), microRNA-125a expression >7.21 units — by 5.18 times (HR 5.18, 95% CI 2.29—11.69, p<0.001), microRNA-125b expression >3.49 units — by 4.03 times (HR 4.03, 95% CI 1.86—8.72, p=0.0001), microRNA-214 expression >2.47 units — by 3.99 times (HR 3.99, 95% CI 1.91—8.37, p<0.001). Expression of microRNA-21 and microRNA-214 was higher in patients with early CAD than in older patients (p<0.05). Expression of microRNA-21, microRNA-125a, microRNA-125b and microRNA-214 was higher in CAD patients with myocardial infarction (MI) than in patients without MI (p<0.05). Conclusion. Expression of microRNA-21, microRNA-125a, microRNA-125b and microRNA-214 was higher in CAD patients than in the comparison group, as well as in CAD patients with MI. Expression of microRNA-21 and microRNA-214 was higher in patients with early CAD than in older patients.
No takes yet. Share an insight, caveat, or question.
Ионова et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: